Erythromycin-resistant Streptococcus pyogenes in Argentina
Medicina (B.Aires)
; Medicina (B.Aires);64(2): 143-145, 2004. tab
Article
em En
| BINACIS
| ID: bin-123264
Biblioteca responsável:
BR1.1
ABSTRACT
Erythromycin (ERY) resistance in Streptococcus pyogenes has recently emerged as a problem of growing concern all through the world. We are presenting the comparison of results of the continuous surveillance of erythromycin resistance in S. pyogenes performed since 1989 in the Hospital de Pediatría J.P.Garrahan of Buenos Aires City, with independently observed rates in other five centers of Buenos Aires and seven centers of six other Argentinian cities, obtained between 1999 and 2001. A significant increase of erythromycin resistance was observed among S. pyogenes isolated in the Hospital Garrahan (6.6% in 1998-1999 to 9.9% in 2000). Similar trends were also detected in other centers of other Argentinian cities when recent data were compared to results of a multicenter study performed in 1995. However, lower rates of resistance were recorded in Mendoza, Cipolletti and Neuquén in comparison with data of 1995, 1998 and 1998 respectively. The reason of such decreasing resistance rates deserves to be investigated. The average of ERY-resistance rates obtained in the surveyed centers was 6.7% (range 0.5-14.1%). Control of antimicrobial use should be performed to warrant the future effectiveness of macrolide antibiotics regarding the positive association between use and resistance. These results also suggest that susceptibility tests for macrolides should be performed whenever S. pyogenes is isolated in Argentina.(AU)
Texto completo:
1
Coleções:
06-national
/
AR
Base de dados:
BINACIS
Assunto principal:
Infecções Estreptocócicas
/
Streptococcus pyogenes
/
Eritromicina
/
Antibacterianos
Tipo de estudo:
Clinical_trials
Limite:
Child
/
Humans
País/Região como assunto:
America do sul
/
Argentina
Idioma:
En
Revista:
Medicina (B.Aires)
Ano de publicação:
2004
Tipo de documento:
Article
País de publicação:
Argentina